Penserra Capital Management LLC Puma Biotechnology, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$2.85 - $6.58 $2,650 - $6,119	-930 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.63 - $9.39 $66 - $93	10 Added 1.09%	930 $6,000
Q2 2021 Aug 12, 2021	BUY	$8.98 - $11.6 $134 - $174	15 Added 1.66%	920 $8,000
Q1 2021 May 13, 2021	SELL	$9.38 - $13.63 $93 - $136	-10 Reduced 1.09%	905 $8,000
Q4 2020 Feb 12, 2021	BUY	$7.78 - $12.13 $4,489 - $6,999	577 Added 170.71%	915 $9,000

Q3 2020 Nov 13, 2020	BUY	$9.5 - $11.14 $3,211 - $3,765	338 New	338 $3,000

135

35.1M

264K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $226M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.